Amylyx Pharmaceuticals Cash Flow Statement 2020-2024 | AMLX

Fifteen years of historical annual cash flow statements for Amylyx Pharmaceuticals (AMLX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020
$49.27$-198.38$-87.93$-42.28
$-8.85$-1.57$0.17$0.00
$37.16$21.71$8.36$2.98
$28.31$20.15$8.54$2.98
$-24.74$-15.31$0$0
$-73.13$-9.77$0$0
$15.88$1.85$0.67$1.42
$-5.27$-4.47$-4.51$-0.76
$-65.66$-1.64$4.60$2.60
$11.92$-179.87$-74.80$-36.70
$-1.24$-2.53$-0.35$-0.15
$0$0$0$0
$0$0$0$0
$93.29$-236.46$-46.05$0
$0$0$0$0
$93.29$-236.46$-46.05$0
$0$0$0$0
$92.05$-238.99$-46.41$-0.15
$0$0$25.90$16.82
$0$0$0$0
$0$0$25.90$16.82
$6.99$435$0.34$0.05
$6.99$435$135$30.01
$0$0$0$0
$-3.45$-2.85$-2.73$0
$3.54$432$159$46.82
$108$12.87$37.31$9.98
$37.16$21.71$3.14$0.24
$0$0$0$0